Captopril pretreatment produces an additive cardioprotection to isoflurane preconditioning in attenuating myocardial ischemia reperfusion injury in rabbits and in humans

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Tian, Yi ^a   Li, Haobo ^b   Liu, Peiyu ^c   Xu, Jun Mei ^d   Irwin, Michael G ^b   Xia, Zhengyuan ^b,e   Tian, Guogang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Department of Gastroenterology   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; ETOMIDATE; FENTANYL; INTERLEUKIN 6; ISOFLURANE; LYMPHOCYTE ANTIGEN; MIDAZOLAM; MORPHINE; PANCURONIUM BROMIDE; SCOPOLAMINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FLOW CYTOMETRY; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE BIOPSY; HEART PROTECTION; HEART VALVE REPLACEMENT; HUMAN; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; MYOCARDIAL APOPTOSIS; MYOCARDITIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SINGLE DRUG DOSE; ANIMAL; CARDIAC MUSCLE; DRUG EFFECTS; DRUG POTENTIATION; HEART INFARCTION PREVENTION; METABOLISM; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; PROCEDURES;

ORYCTOLAGUS CUNICULUS; RODENTIA;

ADULT; ANIMALS; CAPTOPRIL; DRUG SYNERGISM; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; RABBITS;

EID: 84939211935     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/819232     Document Type: Article

References (37)

1. A. L. Hawkes, M. Nowak, B. Bidstrup, and R. Speare, "Outcomes of coronary artery bypass graft surgery," Vascular Health and Risk Management, vol. 2, no. 4, pp. 477-484, 2006.
2. Y. Cao, T. Yang, S. Yu, G. Sun, C. Gu, and D. Yi, "Relationships of adiponectin with markers of systemic inflammation and insulin resistance in infants undergoing open cardiac surgery," Mediators of Inflammation, vol. 2013, Article ID187940, 6 pages, 2013.
3. P. Genereux, D. J. Cohen, M. Mack, et al., "Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement," Journal of the American College of Cardiology, vol. 64, no. 24, pp. 2605-2615, 2014.
4. A. P. Furnary, G. Gao, G. L. Grunkemeier, et al., "Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting," Journal ofThoracic and Cardiovascular Surgery, vol. 125, no. 5, pp. 1007-1021, 2003.
5. S. Yusuf, D. Zucker, P. Peduzzi, et al., "Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration," The Lancet, vol. 344, no. 8922, pp. 563-570, 1994.
6. Z. Huang, X. Zhong, M. G. Irwin, et al., "Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients," Clinical Science, vol. 121, no. 2, pp. 57-69, 2011.
7. D. Belhomme, J. Peynet, M. Louzy, J.-M. Launay, M. Kitakaze, and P. Menasché, "Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery," Circulation, vol. 100, no. 19, supplement, pp. II340-II344, 1999.
8. L. G. Kevin, P. Katz, A. K. S. Camara, E. Novalija, M. L. Riess, and D. F. Stowe, "Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts," Anesthesiology, vol. 99, no. 2, pp. 385-391, 2003.
9. Y. Mio, M. W. Bienengraeber, J. Marinovic, et al., "Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity," Anesthesiology, vol. 108, no. 4, pp. 612-620, 2008.
10. K. Tanaka, F. Kehl, W. Gu, et al., "Isoflurane-induced preconditioning is attenuated by diabetes," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 282, no. 6, pp. H2018-H2023, 2002.
11. G. Clermont, C. Vergely, S. Jazayeri, et al., "Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass," Anesthesiology, vol. 96, no. 1, pp. 80-87, 2002.
12. P. A. Checchia, R. A. Bronicki, J. T. Muenzer, et al., "Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children-a randomized trial," Journal ofThoracic and Cardiovascular Surgery, vol. 146, no. 3, pp. 530-536, 2013.
13. L. Millucci, L. Ghezzi, E. Paccagnini, et al., "Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient,"Mediators of Inflammation, vol. 2014, Article ID258471, 12 pages, 2014.
14. J. Börgermann, I. Friedrich, S. Flohé, et al., "Tumor necrosis factor-α production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokineinhibitory activities," Journal of Thoracic and Cardiovascular Surgery, vol. 124, no. 3, pp. 608-617, 2002.
15. R. Khosravi, K. Ka, T. Huang, et al., "Tumor necrosis factor-α and interleukin-6: potential interorgan inflammatory mediators contributing to destructive periodontal disease in obesity or metabolic syndrome," Mediators of Inflammation, vol. 2013, Article ID 728987, 6 pages, 2013.
16. P. H. Lou, E. Lucchinetti, L. Zhang, et al., "Loss of Intralipid but not sevoflurane-mediated cardioprotection in early type-diabetic hearts of fructose-fed rats: importance of ROS signaling," PLoS ONE, vol. 9, no. 8, Article ID e104971, 2014.
17. H. Wang, L. Wang, N. Li, et al., "Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ROS-activated p38 MAPK/NF-κB signaling," OxidativeMedicine and Cellular Longevity, vol. 2014, Article ID 851692, 13 pages, 2014.
18. F. Kehl, P. S. Pagel, J. G. Krolikowski, et al., "Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo," Anesthesia and Analgesia, vol. 95, no. 5, pp. 1162-1168, 2002.
19. M. Wakeno-Takahashi, H. Otani, S. Nakao, H. Imamura, and K. Shingu, "Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart," American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 6, pp. H2585-H2591, 2005.
20. P. Sogaard, C. O. Gotzsche, J. Ravkilde, and K. Thygesen, "Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction," Circulation, vol. 87, no. 4, pp. 1093-1099, 1993.
21. J. Gurevitch, D. Pevni, I. Frolkis, et al., "Captopril in cardioplegia and reperfusion: protective effects on the ischemic heart," The Annals ofThoracic Surgery, vol. 63, no. 3, pp. 627-633, 1997.
22. A. W. Scribner, J. Loscalzo, and C. Napoli, "The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress," European Journal of Pharmacology, vol. 482, no. 1-3, pp. 95-99, 2003.
23. Y.-H. Liu, Y. You, T. Song, S.-J. Wu, and L.-Y. Liu, "Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril," Journal of Cardiovascular Pharmacology, vol. 50, no. 2, pp. 155-161, 2007.
24. F. M. B. de Gusmão, C. Becker, M. H. C. Carvalho, and L. F. M. Barros, "Angiotensin II inhibition duringmyocardial ischemiareperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction," International Journal of Cardiology, vol. 100, no. 3, pp. 363-370, 2005.
25. W. Linz, G. Wiemer, and B. A. Scholkens, "ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts," Journal of Molecular and Cellular Cardiology, vol. 24, no. 8, pp. 909-919, 1992.
26. Q. Fan, X.-C. Yang, Y. Liu, et al., "Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans," Clinical Science, vol. 120, no. 6, pp. 251-261, 2011.
27. J. Xu, H. Li, M. G. Irwin, et al., "Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription signaling pathway in rats," Critical Care Medicine, vol. 42, no. 8, pp. e583-e594, 2014.
28. D. J. Hausenloy and D. M. Yellon, "Myocardial ischemiareperfusion injury: a neglected therapeutic target," The Journal of Clinical Investigation, vol. 123, no. 1, pp. 92-100, 2013.
29. T. Wang, X. Mao, H. Li, et al., "N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes," Free Radical Biology and Medicine, vol. 63, pp. 291-303, 2013.
30. J. Vinten-Johansen, R. Jiang, J. G. Reeves, J. Mykytenko, J. Deneve, and L. J. Jobe, "Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion injury," Hematology/Oncology Clinics ofNorthAmerica, vol. 21, no. 1, pp. 123-145, 2007.
31. D. M. Yellon and D. J. Hausenloy, "Myocardial reperfusion injury," The New England Journal of Medicine, vol. 357, no. 11, pp. 1074-1135, 2007.
32. G. M. Fröhlich, P. Meier, S. K. White, D. M. Yellon, and D. J. Hausenloy, "Myocardial reperfusion injury: looking beyond primary PCI," European Heart Journal, vol. 34, no. 23, pp. 1714-1724, 2013.
33. N. V. Solenkova, V. Solodushko, M. V. Cohen, and J. M. Downey, "Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt," American Journal of Physiology-Heart and Circulatory Physiology, vol. 290, no. 1, pp. H441-H449, 2006.
34. H. Kin, Z.-Q. Zhao, H.-Y. Sun, et al., "Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion," Cardiovascular Research, vol. 62, no. 1, pp. 74-85, 2004.
35. X. Mao, T. Wang, Y. Liu, et al., "N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats," PLoS ONE, vol. 8, no. 7, Article ID e68949, 2013.
36. A. F. van den Heuvel, W. H. van Gilst, D. J. van Veldhuisen, R. J. de Vries, P. H. Dunselman, and J. H. Kingma, "Longterm anti-ischemic effects of angiotensin-converting enzyme inhibition in patients aftermyocardial infarction. TheCaptopril and Thrombolysis Study (CATS) Investigators," Journal of the American College of Cardiology, vol. 30, no. 2, pp. 400-405, 1997.
37. P. C. Chiari, M. W. Bienengraeber, D. Weihrauch, et al., "Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium," Anesthesiology, vol. 103, no. 1, pp. 74-83, 2005.